hydromorphone has been researched along with pregabalin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Giampetro, DM; Vorobeychik, Y | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Addante, RA; Charlson, MD; Michelson, JD | 1 |
| Casali, M; Dauri, M; Lazzari, M; Sabato, AF; Sabato, E; Tufaro, G | 1 |
2 review(s) available for hydromorphone and pregabalin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
3 other study(ies) available for hydromorphone and pregabalin
| Article | Year |
|---|---|
Topical lidocaine and epidural bupivacaine/hydromorphone in the treatment of complex regional pain syndrome type 2.
Topics: Administration, Topical; Adult; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Causalgia; Chondrosarcoma; Drug Combinations; Drug Synergism; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Leg; Lidocaine; Oxycodone; Pregabalin; Sacrum; Spinal Nerve Roots; Treatment Outcome | 2007 |
Multimodal analgesia therapy reduces length of hospitalization in patients undergoing fusions of the ankle and hindfoot.
Topics: Acetaminophen; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Anesthesia, General; Anesthesia, Spinal; Ankle Joint; Anti-Inflammatory Agents; Arthrodesis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Length of Stay; Male; Middle Aged; Morphine; Oxycodone; Pain Management; Pain, Postoperative; Postoperative Care; Prednisone; Pregabalin; Preoperative Care; Pyrazoles; Retrospective Studies; Subtalar Joint; Sulfonamides | 2013 |
Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Chronic Pain; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Male; Middle Aged; Neuralgia; Pain Management; Pregabalin; Young Adult | 2014 |